Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures

Part of paid clinical trials in Wyomissing, Pennsylvania.

Sponsor
SI-BONE, Inc.
Study ID
NCT07530497
Status
Recruiting
Apply to this trial

Conditions

  • Fracture; Pelvic
  • Fragility Fracture
  • Insufficiency Fractures
  • Sacroiliac Joint Disruption
  • Sacroiliac Joint Dysfunction
  • Sacroiliac; Fusion

Eligibility Criteria

Sex
ALL
Age
60 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • iFuse TORQ TNT Implant System — DEVICE
    FDA-clear implant used for fracture fixation of the pelvis, including acute, non-acute, and non-traumatic fractures and sacroiliac joint fusion for sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis.

Study Details

The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.

Key Dates

First listed
Apr 15, 2026
Start date
Aug 31, 2026
Status verified
Aug 2026
Primary completion
Feb 29, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: FFP using iFuse TORQ TNT.
    Patients with fragility fractures of the pelvis (FFP) treated with surgical fixation using iFuse TORQ TNT.

Primary Outcome Measure

Composite Measure [ Time Frame: 6-months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Orthopaedic Associates of ReadingWyomissingPennsylvania19610
Principal Investigator
[email protected]
610-376-8671

Find similar trials in Wyomissing, PA

By research site
Orthopaedic Associates of Reading· Wyomissing, PA

Related Studies